Literature DB >> 20404156

c-Cbl deficiency leads to diminished lymphocyte development and functions in an age-dependent manner.

Chozhavendan Rathinam1, Richard A Flavell.   

Abstract

Aging is broadly defined as a progressive decline of tissue and organ functions due to deregulation of various cell intrinsic and extrinsic factors. In the immune system, aging preferentially affects lymphopoiesis and thus results in the reduced competence of the adaptive immune system in the elderly. Despite recent discoveries that shed light on the molecular basis of aging, pathways that lead to diminished lymphoid development in aging individuals remain largely unknown. In the present study, we document that a deficiency of the E3 ubiquitin ligase c-Cbl in lymphocytes results in an age-dependent lymphopenia. c-Cbl-deficient mice show normal frequencies of lymphocytes at 12 weeks of age; however, their development and functions were remarkably diminished at 24 weeks after birth. Intriguingly, c-Cbl mutant lymphocytes displayed increased responses to IL7 in vitro and failed to down-regulate surface levels of IL7Ralpha. Further, our biochemical studies have identified an interaction of c-Cbl with IL7Ralpha and have unraveled the involvement of c-Cbl in the ubiquitylation of IL7Ralpha. In essence, our studies demonstrate that a lack of signaling events mediated by c-Cbl might result in diminished lymphocyte development and functions, particularly, at the later stages of life.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20404156      PMCID: PMC2889568          DOI: 10.1073/pnas.0914496107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

Review 1.  Protein regulation by monoubiquitin.

Authors:  L Hicke
Journal:  Nat Rev Mol Cell Biol       Date:  2001-03       Impact factor: 94.444

Review 2.  B cell development pathways.

Authors:  R R Hardy; K Hayakawa
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

Review 3.  The aging of lympho-hematopoietic stem cells.

Authors:  Hartmut Geiger; Gary Van Zant
Journal:  Nat Immunol       Date:  2002-04       Impact factor: 25.606

Review 4.  Interleukin-7: from bench to clinic.

Authors:  Terry J Fry; Crystal L Mackall
Journal:  Blood       Date:  2002-06-01       Impact factor: 22.113

Review 5.  RING finger proteins: mediators of ubiquitin ligase activity.

Authors:  C A Joazeiro; A M Weissman
Journal:  Cell       Date:  2000-09-01       Impact factor: 41.582

6.  Murine pro-B cells require IL-7 and its receptor complex to up-regulate IL-7R alpha, terminal deoxynucleotidyltransferase, and c mu expression.

Authors:  C Wei; R Zeff; I Goldschneider
Journal:  J Immunol       Date:  2000-02-15       Impact factor: 5.422

7.  Pre-B cell receptor signaling mediates selective response to IL-7 at the pro-B to pre-B cell transition via an ERK/MAP kinase-dependent pathway.

Authors:  H E Fleming; C J Paige
Journal:  Immunity       Date:  2001-10       Impact factor: 31.745

8.  Age-associated thymic atrophy is linked to a decline in IL-7 production.

Authors:  Deborah Andrew; Richard Aspinall
Journal:  Exp Gerontol       Date:  2002 Jan-Mar       Impact factor: 4.032

Review 9.  Cbl: many adaptations to regulate protein tyrosine kinases.

Authors:  C B Thien; W Y Langdon
Journal:  Nat Rev Mol Cell Biol       Date:  2001-04       Impact factor: 94.444

Review 10.  Transcriptional regulation of lymphocyte development.

Authors:  Sheila Dias; Wei Xu; Stephanie McGregor; Barbara Kee
Journal:  Curr Opin Genet Dev       Date:  2008-09-05       Impact factor: 5.578

View more
  7 in total

1.  Silencing autocrine death: a ubiquitin ligase that blocks activation-induced cell death in cutaneous T-cell lymphoma.

Authors:  Claus-Detlev Klemke; Maria Feoktistova; Martin Leverkus
Journal:  J Invest Dermatol       Date:  2015-03       Impact factor: 8.551

Review 2.  IL-7: the global builder of the innate lymphoid network and beyond, one niche at a time.

Authors:  Joonsoo Kang; Mark Coles
Journal:  Semin Immunol       Date:  2012-03-13       Impact factor: 11.130

3.  Lack of the ubiquitin-editing enzyme A20 results in loss of hematopoietic stem cell quiescence.

Authors:  Masahiro Marshall Nakagawa; Keyur Thummar; Jonathan Mandelbaum; Laura Pasqualucci; Chozha Vendan Rathinam
Journal:  J Exp Med       Date:  2015-01-26       Impact factor: 14.307

4.  The 'inflammatory' control of hematopoietic stem cells.

Authors:  Chozha Rathinam
Journal:  Oncotarget       Date:  2015-08-21

Review 5.  Roles of JAK2 in Aging, Inflammation, Hematopoiesis and Malignant Transformation.

Authors:  Florian Perner; Caroline Perner; Thomas Ernst; Florian H Heidel
Journal:  Cells       Date:  2019-08-08       Impact factor: 6.600

Review 6.  Cracking the Monoubiquitin Code of Genetic Diseases.

Authors:  Raj Nayan Sewduth; Maria Francesca Baietti; Anna A Sablina
Journal:  Int J Mol Sci       Date:  2020-04-25       Impact factor: 5.923

7.  A20 deficiency in hematopoietic stem cells causes lymphopenia and myeloproliferation due to elevated Interferon-γ signals.

Authors:  Masahiro Marshall Nakagawa; Chozha Vendan Rathinam
Journal:  Sci Rep       Date:  2019-09-02       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.